Valuation : Becton, Dickinson and Company

Market Cap 48.98B 42.14B 39.68B 36.16B 67.65B 4,660B 67.92B 470B 182B 2,374B 184B 180B 7,521B P/E 2026 *
34.6x
P/E 2027 * 19.3x
Enterprise Value 64.86B 55.81B 52.55B 47.88B 89.59B 6,172B 89.95B 623B 241B 3,144B 244B 238B 9,961B EV / Sales 2026 *
3.36x
EV / Sales 2027 * 3.19x
Free-Float
73.18%
Yield 2026 *
2.18%
Yield 2027 * 2.22%
1 day+0.98%
1 week-4.12%
Current month-4.42%
1 month+1.66%
3 months+18.26%
6 months+8.67%
Current year-7.35%
1 week 176.55
Extreme 176.55
187.13
1 month 176.55
Extreme 176.55
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
269.52
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Tax

Chief Financial Officer

-190 0.0001%
8/26/26 Sell

Executive/Senior Manager

-165 0.0001%
8/20/26 Tax

Executive/Senior Manager

-1,049 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.98%-4.12%-5.61%-32.60% 48.78B
-0.27%-4.74%-20.25%+4.47% 183B
-0.54%-0.31%-2.32%+14.92% 118B
-0.42%-3.88%+8.25%+81.95% 61.96B
-0.65%-5.51%+12.15%+43.50% 50.6B
-0.77%-6.48%+6.99%-19.62% 31.9B
-1.84%-6.20% - - 30.44B
-0.24%-1.66%+33.69%-14.30% 23.77B
-2.20%-10.00%-15.00%+3.73% 22.26B
-1.53%-6.62%-13.41%-3.44% 21.3B
Average -0.72%-2.94%+0.50%+8.74% 59.18B
Weighted average by Cap. -0.48%-2.00%-4.84%+13.03%

Financials

2026 *2027 *
Net sales 19.29B 16.6B 15.63B 14.24B 26.65B 1,836B 26.75B 185B 71.6B 935B 72.44B 70.86B 2,963B 19.73B 16.98B 15.99B 14.57B 27.26B 1,878B 27.37B 189B 73.24B 957B 74.1B 72.49B 3,031B
Net income 1.44B 1.24B 1.16B 1.06B 1.98B 137B 1.99B 13.8B 5.33B 69.64B 5.39B 5.28B 221B 2.34B 2.01B 1.9B 1.73B 3.23B 223B 3.24B 22.47B 8.68B 113B 8.78B 8.59B 359B
Net Debt 15.88B 13.67B 12.87B 11.73B 21.94B 1,512B 22.03B 153B 58.95B 770B 59.65B 58.35B 2,440B 13.95B 12.01B 11.3B 10.3B 19.27B 1,328B 19.35B 134B 51.78B 676B 52.39B 51.25B 2,143B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-09-09 $179.80 +0.39% 1,529,001
26-09-08 $179.10 -3.05% 1,805,619
26-09-04 $184.74 -1.54% 1,439,133
26-09-03 $187.62 +0.05% 1,206,509
26-09-02 $187.52 +0.21% 1,474,463
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
179.80USD
Average target price
195.67USD
Spread / Average Target
+8.82%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!